NDC 63629-3370

Depakote ER

Divalproex Sodium

Depakote ER is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Divalproex Sodium.

Product ID63629-3370_209f343f-13a2-4cfe-b666-2371d7a3f04e
NDC63629-3370
Product TypeHuman Prescription Drug
Proprietary NameDepakote ER
Generic NameDivalproex Sodium
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2000-08-04
Marketing CategoryNDA / NDA
Application NumberNDA021168
Labeler NameBryant Ranch Prepack
Substance NameDIVALPROEX SODIUM
Active Ingredient Strength500 mg/1
Pharm ClassesAnti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 63629-3370-1

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-3370-1)
Marketing Start Date2007-02-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63629-3370-1 [63629337001]

Depakote ER TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021168
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-06-07
Inactivation Date2019-11-27

NDC 63629-3370-2 [63629337002]

Depakote ER TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021168
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-06-07
Inactivation Date2019-11-27

NDC 63629-3370-3 [63629337003]

Depakote ER TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021168
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-06-07
Inactivation Date2019-11-27

NDC 63629-3370-4 [63629337004]

Depakote ER TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021168
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-06-07
Inactivation Date2019-11-27

Drug Details

Active Ingredients

IngredientStrength
DIVALPROEX SODIUM500 mg/1

OpenFDA Data

SPL SET ID:942c853a-9eb9-4454-b686-b45d8df8db39
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1099571
  • 1099569
  • Pharmacological Class

    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]
    • Mood Stabilizer [EPC]

    NDC Crossover Matching brand name "Depakote ER" or generic name "Divalproex Sodium"

    NDCBrand NameGeneric Name
    70518-1758Depakote ERDepakote ER
    70518-1759Depakote ERDepakote ER
    43353-310Depakote ERDepakote ER
    63629-3370Depakote ERDepakote ER
    0074-3826DepakoteDivalproex Sodium
    0074-6114DepakoteDivalproex Sodium
    0074-6212DepakoteDivalproex Sodium
    0074-6214DepakoteDivalproex Sodium
    0074-6215DepakoteDivalproex Sodium
    0074-7126DepakoteDivalproex Sodium

    Trademark Results [Depakote]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    DEPAKOTE
    DEPAKOTE
    75295484 2197507 Dead/Cancelled
    SANOFI-AVENTIS
    1997-05-21
    DEPAKOTE
    DEPAKOTE
    73383028 1377834 Live/Registered
    SANOFI
    1982-09-01

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.